Top IPOs of 2021 – Investment U

Looking for the top IPOs of 2021? Weve compiled a list of the top five IPOs for each month. It provides the ticker symbols, information about the companies, and financial data. Youll also find links to each companys preliminary prospectus.

Sidus Space is a provider of satellite and space services and defense manufacturing. It focuses on commercial satellite design, manufacture, launch and data collection. As part of its vision, the company plans to demonstrate space operations for new technologies and provide data and predictive analytics.

For the nine months ended September 2020, Sidus Space reported $1.4 million in cash. The companys revenue declined more than 70% to $413,000 for the same period in 2021. Sidus Spaces net losses increased from $1.2 million in September 2020 to $1.3 million in September 2021. The companys operating expenses were $1.2 for the nine months ended September 2020. For the same period in 2021, operating expenses rose to $1.7 million.

The company filed November 23 and priced on December 13. It issued 3 million shares under the ticker symbol SIDU. The company priced at the midpoint of its $4 to $6 range at $5 per share. A $15 million profit came from the offering. The companys market cap is $170.1 million.

You can look at Sidus Spaces prospectus here.

First Day Return: 143.8%

Bionomics is an Australian clinical-stage biotech company. Its developing allosteric ion channel modulators for central nervous system disorders. Bionomics lead product candidate, BNC210, is an oral proprietary selective NAM of the 7 receptor. The drug candidate is for acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD).

Bionomics recorded cash is $21.4 million as of June 2021. For the 2020 fiscal year, Bionomics recorded $5.1 million in losses. For the same period in 2021, the companys recorded losses rose to $6.3 million. Bionomics net assets rose from $9.1 million in fiscal 2020 to $34.3 million in fiscal 2021.

Bionomics filed on November 22 and priced on December 15. Shares listed under the ticker BNOX on the Nasdaq exchange. The company priced at $12.35 per share. The company offered 1.6 million shares of common stock for a $20 million offering. Bionomics has a $91.2 million market cap.

You can look at Bionomics prospectus here.

First Day Return: 19.3%

Nu Holdings is a digital banking service. Its the largest fintech bank in Latin America. It has over 48 million customers across Brazil, Mexico and Colombia as of September 30, 2021. The company offers a variety of banking services. This includes a free digital bank account, credit and debit cards and personal loans. It also offers peer-to-peer money transfers, life insurance and business banking.

As of September 2021, Nu Holdings recorded nearly $2 billion in cash. The company recorded $10.2 billion in total assets as of December 2020. In nine months, the companys total assets skyrocketed to $15 billion. Total liabilities were reported at $9.7 billion as of December 2020 and rose to $13 billion by September 2021.

Nu Holdings filed on November 1 and priced on December 8. Shares listed under the ticker NU on the New York Stock Exchange (NYSE). The offering consisted of 289 million shares. The company priced at the top end of its expected $8 to $9 range for a $2.6 billion deal. The Nu Holdings IPO gave the company a market cap of almost $46 billion.

You can look at Nu Holdings prospectus here. Check out more information about the Nu Holdings IPO.

First Day Return: 14.8%

Samsara is a developer of end-to-end Internet of Things solutions for businesses. The company provides fleet monitoring and management software to vehicle operators. The company provides a cloud-based platform to provide software solutions that improve safety and efficiency. Samsara offers sensors and cameras to generate data into actionable insights on operational assets like delivery vehicles, fleets of construction trucks and physical locations.

Samaras revenue for the nine months ended October 2020 and October 2021 was $174.0 million and $302.6 million representing year-over-year growth of 74%. Net losses were $174 million and $102.3 million for the nine months ended October 2020 and October 2021. The company recorded $201.1 million in cash in February 2020. A year later, cash grew to $400 million.

Samsara filed on November 19 and set its terms on December 6. Shares listed under the ticker IOT on the New York Stock Exchange (NYSE). The offering consisted of 35 million shares priced at $23 per share of common stock. This was at the top end of the companys proposed $20 to $23 price range. The company raised $805 million in its initial public offering. Samsara has a market cap of $13.7 billion.

You can look at Samsaras prospectus here. Check out more information about the Samsara IPO.

First Day Return: 7.4%

HashiCorp develops cloud infrastructure management software. The company offers solutions that provide a consistent cloud operating model that can build, secure, connect and deploy any infrastructure for any application. The company is a leading provider of multi-cloud infrastructure automation. It helps developers manage their cloud infrastructure across major public clouds. This includes Amazon, Microsoft and Google.

For the 2019 fiscal year, HashiCorp recorded $121.3 million in total revenue. In 2020, total revenue grew to $211.9 million. The company recorded $53.4 million and $83.5 million for the 2019 and 2020 fiscal years. HashiCorp recorded $270.8 million in cash in January 2021. However, as of October 2021, cash decreased to $218.2 million.

HashiCorp filed on November 4 and priced on December 8. Shares listed under the ticker HCP on the Nasdaq exchange. Shares priced above the expected $68 to $72 range at $80 per share of common stock. The company offered $15.3 million shares for a $1.2 billion offering. HashiCorp has a market cap of $15.1 billion.

You can look at HashiCorps prospectus here. Check out more information about the HashiCorp IPO.

First Day Return: 6.5%

AeroClean provides air purification technology for interior spaces. The company is focused on commercializing its sterilization and disinfection products to eliminate harmful airborne pathogens, including COVID-19. The company treats hospital and non-hospital healthcare facilities. This includes outpatient chemotherapy centers, senior living centers and nursing homes, schools and universities, commercial properties and other indoor spaces.

AeroClean recorded $153,000 in losses for the year 2019. The companys losses skyrocketed to $3.3 million for 2020. In 2019, AeroClean recorded just $796 in total assets. In 2020, total assets rose to $3.2 million. AeroClean reported $231,400 in total liabilities in 2019. In 2020, the companys recorded liabilities rose to $655,300.

The company filed September 21 and priced on November 23. It issued 2.5 million shares under the ticker symbol AERC. The company priced at the bottom of its $10 to $12 range at $10 per share. A $25 million profit came from the offering. The companys market cap is $255 million.

You can look at AeroClean Technologies prospectus here.

First Day Return: 689.4%

Society Pass acquires and operates e-commerce platforms in South Asia. Society Pass is headquartered in Singapore. The company markets to both consumers and merchants in Vietnam. The company operates in two segments: a consumer facing segment and a merchant facing segment. The consumer-facing segment includes SoPa food & beverage Loyalty App, SoPa.asia Loyalty Marketplace, Leflair App and the Leflair Lifestyle Marketplace website. The merchant facing segment includes #HOTTAB Biz App, #HOTTAB POS App and Hottab.net.

Society Pass recorded revenue was $10,400 in 2019. In 2020, revenue skyrocketed to $52,500. The company narrowed its losses in 2020. Net losses stood at $7.3 million for 2019 and lowered to $3.8 million in 2020. Society Pass recorded $8.7 million in total assets in 2019 and $7.9 million in 2020. Total liabilities increased from $2.3 million in 2019 to $3 million in 2020.

Society Pass filed on July 20 and priced on November 8. Shares listed under the ticker SOPA on the Nasdaq exchange. The company priced at the midpoint of its $8 to $10 price range at $9 per share. The company offered 2.9 million shares of common stock for a $26 million offering. Society Pass has a $149.9 million market cap.

You can look at Society Pass prospectus here.

First Day Return: 436.7%

Sono Group is a German-based developer of solar powered vehicles. It is on a mission to provide a net-zero-emission vehicle solution for the mass market. The company specializes in solar electric vehicles (SEVs) that use solar energy to generate an extra charge. Sono Group is currently developing the Sion, the worlds first solar electric vehicle.

Sono Group has not recorded any revenue and reported consistent losses. The company reported losses of 56 million ($63.4 million) in the year 2020. Sono Group recorded 5.7 million ($6.4 million) in total assets as of 2019. Total assets stand at 38.6 million ($43.7 million) as of June 30, 2021. In 2019, The company recorded 24.3 million ($27.5 million) in total liabilities. Liabilities grew to 66.8 million ($75.6 million) as of June 30.

Sono Group filed on October 22 and priced on November 16. Shares listed under the ticker SEV on the Nasdaq exchange. The offering consisted of 10 million shares. The company priced at the midpoint of its expected $14 to $16 range for a $150 million deal. The IPO gave the company a post valuation of $963.7 million.

You can look at Sono Groups prospectus here.

First Day Return: 154.7%

Mainz Biomed is a molecular genetics cancer diagnostic company. The companys portfolio consists of

Mainz Biomed recorded $281,400 in revenue in 2019 and $493,600 in 2020. For the year ended 2019, the company reported $1 million in losses. By 2020, the company net losses narrowed to $600,000. As of June 2021, Mainz Biomed has $730,000 in total assets and $3.1 million in total liabilities. The company has $2.1 million in long-term debt as of June 2021.

Mainz Biomed filed on October 12 and priced on November 4. Shares listed under the ticker MYNZ on the Nasdaq exchange. The offering consisted of 2 million shares priced at $5 per share of common stock. This was at the midpoint of the companys proposed $4 to $6 price range. The company raised $10 million in its initial public offering. It has a market cap of $103.6 million.

You can look at Mainz Biomeds prospectus here.

First Day Return: 99.8%

Allbirds is a global lifestyle brand that makes footwear using naturally derived materials. The company uses resources like wool, trees, crab shells, eucalyptus and sugarcane. Allbirds footwear has a 30% lower carbon footprint than a regular pair of trainers. The global lifestyle brands supply chain has been carbon neutral since 2019.

Allbirds has faced losses since inception. The company recorded $193.7 million in net revenue for the 2019 fiscal year. In 2020, Allbirds reported over $219.3 million for the year. It recorded a gross profit of $98.8 million for 2019 and $112.7 million in 2020. As of December 2020, Allbirds has over $244 million in total assets and $65.5 million in total liabilities.

Allbirds filed on August 31 and priced on November 2. Shares listed under the ticker BIRD on the Nasdaq exchange. Shares priced above the expected $12 to $14 range at $15 per share of common stock. The company offered $20.2 million shares for a $303 million offering. Allbirds has a market cap of $2.3 billion.

You can look at Allbirds prospectus here.

First Day Return: 92.6%

Volcon is an all-electric, off-road powersports vehicle company. It develops and builds electric motorcycles and utility terrain vehicles (UTVs). In October 2020, the company began building and testing prototypes for two off-road motorcycles the Grunt and the Runt. Volcon is accepting orders for motorcycles on its website.

Volcon was founded in 2020. From February to December 2020, the company reported $1.4 million in losses. The companys net losses rose more than 600% to $19.5 million for the six months ending in June 2021. Volcons cash is $6 million and total assets are $12.1 million as of June 30.

The company filed September 10 and priced on October 5. It issued 3 million shares under the ticker symbol VLCN. The company priced at the top of its $4.50 to $5.50 range at $5.50 per share. A $17 million profit came from the offering. The companys market cap is $152.5 million.

You can look at Volcons prospectus here.

First Day Return: 97.5%

Stronghold Digital Mining is a bitcoin mining company. The company owns and operates using environmentally-beneficial coal refuse power. It claims to be one of the first vertically integrated crypto asset mining companies with a focus on environmentally-beneficial operations.

Stronghold Digital Minings recorded operating revenue was $4.1 million for the year 2020. For the six months ended June 2021, Stronghold Digital Mining recorded $7.9 million in operating revenue. For the year 2020, the companys recorded long-term debt was $1.8 million. As of June 30, the companys long-term debt rose to $18.9 million.

Stronghold Digital Mining filed on July 27 and priced on October 19. Shares listed under the ticker SDIG on the Nasdaq exchange. The company priced above its $16 to $18 price range at $19 per share. The company offered 6.7 million shares of common stock for a $127 million offering. Stronghold Digital Mining has a $558.5 million market cap.

You can look at Stronghold Digital Minings prospectus here.

First Day Return: 52.1%

Portillos is a fast-food restaurant chain known for its Chicago-style hot dogs. The company started in 1963 and has grown to a nationwide following. It offers a diverse menu featuring all-American favorites. This includes Chicago-style hot dogs and sausages, Italian sandwiches, chopped salads, burgers, french fries, homemade chocolate cake and milkshakes.

Portillos recorded $479.4 million in revenue for the year 2019 and $455.5 million for 2020. In 2019, Portillos recorded $5.6 million in net income. In 2020, net income rose to $12.3 million. As of June 2021, Portillos has $54.2 million in cash. Portillos has $924 million in total assets and $568.3 million in total liabilities as of June.

Portillos filed on September 27 and priced on October 20. Shares listed under the ticker PTLO on the Nasdaq exchange. The offering consisted of 20.3 million shares. The company priced at the top end of its expected $17 to $20 range for a $405 million deal. The IPO gave the company a post valuation of about $1.6 billion.

You can look at Portillos prospectus here.

First Day Return: 45.5%

AirSculpt Technologies is a leading provider of body contouring procedures in the U.S. The company offers body contouring procedures in 16 centers across 13 states as of October 5, 2021. In 2020, it performed over 5,800 body contouring procedures in 2020. The company offers minimally invasive procedures that dont involve a needle, scalpel, stitches or general anesthesia.

AirSculpt Technologies recorded $41.2 million in revenue in 2019 and $62.8 million in 2020. For the year ended 2019, the company reported $2.2 million in losses. By 2020, the company reported $7.6 million in income. In 2020, AirSculpt Technologies had $179.6 million in total assets and $55.9 million in total liabilities.

AirSculpt Technologies filed on October 5 and priced on October 28. Shares listed under the ticker AIRS on the Nasdaq exchange. The offering consisted of seven million shares priced at $11 per share of common stock. This was at the low end of the companys proposed $11 to $12 price range. The company raised $77 million in its initial public offering. It has a market cap of $807.9 million.

You can look at AirSculpt Technologies prospectus here.

First Day Return: 44.5%

GitLab provides software development and collaboration tools for programmers. The company believes in an innovative world powered by software. To achieve its vision, GitLab pioneered The DevOps Platform. Its a single application that brings together development, operations, IT, security and business teams to deliver desired business outcomes. It consists of a single codebase and interface with a unified data model.

The company has increased its revenue since 2020. For that fiscal year, revenue was $81.2 million. GitLabs revenue rose in 2021 to $152.2 million. The company reported $71.9 million in gross profit for fiscal 2020 and $133.7 million in 2021. GitLab recorded $130.7 million in net losses for fiscal 2020 and $192.2 million for fiscal 2021.

GitLab filed on September 17 and priced on October 13. Shares listed under the ticker GTLB on the Nasdaq exchange. Shares priced above the expected $66 to $69 range at $77 per share of common stock. The company offered $10.4 million shares for an $801 million offering. GitLab has a market cap of $17 billion.

You can look at GitLabs prospectus here.

First Day Return: 34.9%

Dice Therapeutics is a biopharmaceutical company based in San Francisco, California. It works to develop innovative therapies in immunology for patients with chronic diseases. The company aims to develop convenient oral alternatives to medicines that are currently limited to injectable forms.

For 2019, DICE Therapeutics reported $8.5 million in cash. The companys cash rose more than 600% to 59.7 million for 2020. DICE Therapeutics total assets were $31.2 million in December 2019. By the end of 2020, the companys total assets more than doubled to $63.9 million. The firms total liabilities rose from $5.1 million in 2019 to $63.9 million in 2020.

The company filed August 25 and priced on September 14. It issued 12 million shares under the ticker symbol DICE. The company priced at the top of its $15 to $17 range at $17 per share. A $204 million profit came from the offering. The companys market cap is $1.2 billion.

You can look at DICE Therapeutics prospectus here.

First Day Return: 117%

PROCEPT BioRobotics is a surgical robotics company based in California. The company aims to enable better patient care by developing transformative urology solutions. Its initial focus on benign prostatic hyperplasia (BPH) enabled the company to develop the first FDA-cleared Aquablation therapy.

PROCEPT BioRobotics recorded cash is $159.2 million as of June 30. For the year ended December 2019, PROCEPT BioRobotics recorded $6.2 million in total revenue. For the same period in 2020, the companys recorded revenue rose to $7.7 million. As of June 30, the company has $190.6 in total assets.

PROCEPT BioRobotics filed on August 18 and priced on September 14. Shares listed under the ticker PRCT on the Nasdaq exchange. The company priced above its $22 to $24 price range at $25 per share. The company offered 6.6 million shares of common stock for a $164 million offering. PROCEPT BioRobotics has a $1.65 billion market cap.

You can look at PROCEPT BioRobotics prospectus here.

First Day Return: 67.8%

Tyra Biosciences is a precision oncology company that develops therapies to overcome tumor resistance and improve outcomes for cancer patients. The company aims to develop solutions to overcome acquired drug resistance. It uses its SNP platform to generate next-generation product candidates that are designed to address acquired drug resistance and provide alternative treatments.

As of June 30, Tyra Biosciences recorded $135.2 million in cash. Tyra Biosciences recorded $528 thousand in total assets for the 2019 year. In a year, the companys total assets skyrocketed to $16 million. Total liabilities were reported at $5.3 million for 2019 and lowered to $2 million for 2020.

Tyra Biosciences filed on August 20 and priced on September 14. Shares listed under the ticker TYRA on the Nasdaq exchange.The offering consisted of 10.8 million shares. The company priced at the top end of its expected $14 to $16 range for a $173 million deal. The Tyra Biosciences IPO gave the company a post valuation of about $627.4 million.

You can look at Tyra Biosciences prospectus here.

First Day Return: 62.5%

Definitive Healthcare is a leading provider of healthcare commercial intelligence. The company uses SaaS solutions to reduce complexity and streamline insights that help clients grow their business. The companys vision is to create new paths to commercial success in the healthcare market.

Definitive Healthcare recorded $38.4 million in cash as of June 30. For the year ended December 2020, the company reported $118.3 in revenue and $87.8 million in gross profit. For the six months ended June 30, 2020, the company recorded $76.8 million in revenue and $57.5 million in gross profit.

Definitive Healthcare filed on August 20 and priced on September 14. Shares listed under the ticker DH on the Nasdaq exchange. The offering consisted of 115.6 million shares priced at $27 per share of common stock. This was above the companys proposed $24 to $26 price range. The company raised $420 million in its initial public offering.

You can look at Definitive Healthcares prospectus here.

First Day Return: 60.3%

Original post:
Top IPOs of 2021 - Investment U